EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of ACSBG1 in Brain Lipid Metabolism and X-Linked Adrenoleukodystrophy Pathogenesis: Insights from a Knockout Mouse Model

Xiaoli Ye, Yuanyuan Li, Domingo González-Lamuño iD, Zhengtong Pei, Ann B Moser iD, Kirby D Smith, Paul A Watkins

Cells · 2024

DOI: 10.3390/cells13201687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Xiaoli Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, Mice, Knockout, Brain, Lipid Metabolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NICHD NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“Bubblegum” acyl-CoA synthetase (ACSBG1) is a pivotal player in lipid metabolism during mouse brain development, facilitating the activation of long-chain fatty acids (LCFA) and their incorporation into lipid species that are crucial for brain function. ACSBG1 converts LCFA into acyl-CoA derivatives, supporting vital metabolic processes. Fruit fly mutants lacking ACSBG1 exhibited neurodegeneration and had elevated levels of very long-chain fatty acids (VLCFA), characteristics of human X-linked adrenoleukodystrophy (XALD). To explore ACSBG1’s function and potential as a therapeutic target in XALD, we created an ACSBG1 knockout (Acsbg1−/−) mouse and examined the effects on brain FA metabolism during development. Phenotypically, Acsbg1−/− mice resembled wild type (w.t.) mice. ACSBG1 expression was found mainly in tissue affected pathologically in XALD, namely the brain, adrenal gland and testis. ACSBG1 depletion did not significantly reduce the total ACS enzyme activity in these tissue types. In adult mouse brain, ACSBG1 expression was highest in the cerebellum; the low levels detected during the first week of life dramatically increased thereafter. Unexpectedly, lower, rather than higher, saturated VLCFA levels were found in cerebella from Acsbg1−/− vs. w.t. mice, especially after one week of age. Developmental changes in monounsaturated ω9 FA and polyunsaturated ω3 FA levels also differed between w.t. and Acsbg1−/− mice. ACSBG1 deficiency impacted the developmental expression of several cerebellar FA metabolism enzymes, including those required for the synthesis of ω3 polyunsaturated FA, precursors of bioactive signaling molecules like eicosanoids and docosanoids. These changes in membrane lipid FA composition likely affect membrane fluidity and may thus influence the body’s response to inflammation. We conclude that, despite compelling circumstantial evidence, it is unlikely that ACSBG1 directly contributes to the pathology of XALD, decreasing its potential as a therapeutic target. Instead, the effects of ACSBG1 knockout on processes regulated by eicosanoids and/or docosanoids should be further investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenoleukodystrophyMice, KnockoutBrainLipid MetabolismCoenzyme A LigasesDisease Models, AnimalAnimalsMiceMaleFatty AcidsMice, Inbred C57BL

Stichwörter der Autor:innen

ACSBG1X-linked adrenoleukodystrophybrain fatty acid levelsbubblegumeicosanoids and docosanoidsinflammationmembrane fluidityvery long-chain fatty acid

Substanzen

Coenzyme A LigasesFatty Acids

Autor:innen und Institutionen

  • Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Genetic Medicine and the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

ORCID-Profile: Domingo González-Lamuño, Ann B Moser

Förderung

  • NIH HHS
  • NICHD NIH HHS
  • NINDS NIH HHS
  • NIH

Zitieren

APA

Ye, X., Li, Y., González-Lamuño, D., Pei, Z., Moser, A. B., Smith, K. D., & Watkins, P. A. (2024). Role of ACSBG1 in Brain Lipid Metabolism and X-Linked Adrenoleukodystrophy Pathogenesis: Insights from a Knockout Mouse Model. Cells. https://doi.org/10.3390/cells13201687

Vancouver

Ye X, Li Y, González-Lamuño D, Pei Z, Moser AB, Smith KD, et al. Role of ACSBG1 in Brain Lipid Metabolism and X-Linked Adrenoleukodystrophy Pathogenesis: Insights from a Knockout Mouse Model. Cells. 2024. doi:10.3390/cells13201687

BibTeX
@article{Ye2024,
  author = {Ye, Xiaoli and Li, Yuanyuan and González-Lamuño, Domingo and Pei, Zhengtong and Moser, Ann B and Smith, Kirby D and Watkins, Paul A},
  title = {Role of ACSBG1 in Brain Lipid Metabolism and X-Linked Adrenoleukodystrophy Pathogenesis: Insights from a Knockout Mouse Model},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13201687}
}
Kostenlos starten →